Capacity to manufacture under Canada's Access to Medicines Regime

To participate in the Regime, an eligible importing country must declare that it has insufficient or no pharmaceutical manufacturing capacity in relation to the specific product it is requesting. It is up to each country to determine for itself the level of its manufacturing capacity.

Publisher

Health Canada

Resources

2

Catalogue metadata updated

2020-09-17